| Management of metastatic bone disease | Lifetime | 52 | DE 2 | 98.83 |
| Cancer Diagnosis and Treatment | Lifetime | 152 | DE 4 | 98.95 |
| Spinal Fractures and Fixation Techniques | Lifetime | 140 | DE 6 | 99.26 |
| Spine and Intervertebral Disc Pathology | Lifetime | 217 | DE 9 | 99.20 |
| Glioma Diagnosis and Treatment | Lifetime | 381 | DE 53 | 98.79 |
| Brain Metastases and Treatment | Lifetime | 160 | DE 10 | 98.70 |
| Head and Neck Cancer Studies | Lifetime | 297 | DE 8 | 98.74 |
| Lung Cancer Research Studies | Lifetime | 419 | DE 13 | 98.44 |
| Meningioma and schwannoma management | Lifetime | 298 | DE 33 | 98.31 |
| Head and Neck Surgical Oncology | Lifetime | 470 | DE 21 | 97.93 |
| Oral health in cancer treatment | Lifetime | 209 | DE 5 | 95.13 |
| Neuroblastoma Research and Treatments | Lifetime | 879 | DE 86 | 95.94 |
| Spinal Hematomas and Complications | Lifetime | 246 | DE 10 | 93.26 |
| Effects of Radiation Exposure | Lifetime | 823 | DE 66 | 92.96 |
| Erythropoietin and Anemia Treatment | Lifetime | 792 | DE 58 | 90.17 |
| Cancer Diagnosis and Treatment | 2021-2025 | 54 | DE 3 | 94.93 |
| Management of metastatic bone disease | 2021-2025 | 43 | DE 3 | 96.12 |
| Head and Neck Cancer Studies | 2021-2025 | 249 | DE 7 | 96.11 |
| Cancer survivorship and care | 2021-2025 | 246 | DE 14 | 95.23 |
| Brain Metastases and Treatment | 2021-2025 | 210 | DE 28 | 93.79 |
| Head and Neck Surgical Oncology | 2021-2025 | 220 | DE 11 | 93.32 |
| Oral health in cancer treatment | 2021-2025 | 58 | DE 1 | 92.13 |
| Glioma Diagnosis and Treatment | 2021-2025 | 810 | DE 102 | 93.55 |
| Effects of Radiation Exposure | 2021-2025 | 122 | DE 9 | 89.71 |
| Spine and Intervertebral Disc Pathology | 2021-2025 | 946 | DE 26 | 91.63 |
| Salivary Gland Tumors Diagnosis and Treatment | 2021-2025 | 314 | DE 15 | 87.08 |
| Cancer-related cognitive impairment studies | 2021-2025 | 314 | DE 9 | 82.20 |
| Chemotherapy-related skin toxicity | 2021-2025 | 111 | DE 5 | 78.57 |
| Family Support in Illness | 2021-2025 | 958 | DE 66 | 75.20 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 996 | DE 92 | 71.94 |
| Ear and Head Tumors | 2021-2025 | 914 | DE 43 | 63.15 |